Sort
10,766 grants matching “checkpoint inhibitor”
Ras18-mediated Fanconi Anemia pathway activation in response to camptothecin
$228,690Komaraiah Palle · University Of South Alabama · R01 · FY2014 · GM
PROTEASES AND CHEMOTHERAPY INDUCED APOPTOSIS
$228,399Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · CA
Directed Purinergic Signaling as Immunotherapy in Leukemia
$228,375Simon C Robson · Beth Israel Deaconess Medical Center · R21 · FY2018 · CA
Metabolic adaptation enables cisplatin resistance and inhibits tumor immunity
$228,275Vlad C Sandulache · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Regulation of the innate immune response in the tumor microenvironment of lung adenocarcinoma
$228,099Glenn Edward Simmons · Cornell University · K01 · FY2024 · CA
Mkp-1 suppresses immune checkpoint protein PD-L1 to prevent sepsis-associated immune dysfunction and mortality
$228,000Yusen Liu · Research Inst Nationwide Children'S Hosp · R21 · FY2019 · AI
Checkpoints of TNF Gene Regulation
$227,980Anne Goldfeld · Boston Children'S Hospital · R01 · FY2012 · GM
Checkpoint Abrogation and MEK 1/2 Inhibition in Myeloma
$227,936Steven Grant · Virginia Commonwealth University · R01 · FY2013 · CA
Modulation of metabolism in TILs by the checkpoint inhibitor PSGL-1
$227,906Linda Mac Pherson Bradley · Sanford Burnham Prebys Medical Discovery Institute · R21 · FY2021 · CA
A novel gene therapy approach targeting STING-silenced cold tumors
$227,906Jianxin You · University Of Pennsylvania · R21 · FY2023 · CA
Arginine Availability, Modulated by MDSC, Regulates T Cell Function in Cancer
$227,896Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2013 · CA
Project 1: Targeting Metabolic Dependencies in PDAC
$227,876Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · P01 · FY2017 · CA
INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY
$227,753University Of North Texas Hlth Sci Ctr · R01 · FY2002 · CA
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
$227,207Timothy C Chambers · Univ Of Arkansas For Med Scis · R01 · FY2012 · CA
Bcl-2 Proteins in Mechanism of Anti-mitotic Drug Action
$227,207Timothy C Chambers · Univ Of Arkansas For Med Scis · R01 · FY2011 · CA
Prostate cancer-associated SPOP mutations modulate innate immune response and immune checkpoint therapy
$227,205Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R21 · FY2021 · CA
Project 1: Elucidating the role of AAA ATPase TRIP13 in prostate cancer
$227,200Rajesh Singh · Morehouse School Of Medicine · U54 · FY2021 · CA
Mitotic Mechanisms in Alzheimer's Disease
$227,200University Of Washington · R01 · FY2005 · AG
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
$226,873Meredith A Morgan · University Of Michigan At Ann Arbor · P50 · FY2024 · CA
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
$226,844Meredith A Morgan · University Of Michigan At Ann Arbor · P50 · FY2023 · CA
BRCAL AND P21 IN CELL CYCLING
$226,627University Of Pennsylvania · R01 · FY2001 · CA
Regulation of the Anaphase-Promoting Complex
$226,590University Of Texas Sw Med Ctr/Dallas · R01 · FY2004 · GM
Regulation of the Anaphase-Promoting Complex
$226,590University Of Texas Sw Med Ctr/Dallas · R01 · FY2003 · GM
Regulation of the Anaphase-Promoting Complex
$226,590University Of Texas Sw Med Ctr/Dallas · R01 · FY2002 · GM
Regulation of the Anaphase-Promoting Complex
$226,590University Of Texas Sw Med Ctr/Dallas · R01 · FY2005 · GM